Abbott's FreeStyle® Libre 2 iOS App Cleared in U.S., Providing a Seamless Digital Experience to Simplify Diabetes Management - Aug 2, 2021

Abbott announced today that the U.S. Food and Drug Administration (FDA) has cleared the FreeStyle® Libre 2 iOS application for use with compatible iPhones1, providing a comprehensive digital

FreeStyle Libre 2 Connected to Your Phone

FreeStyle Libre Continuous Glucose Monitoring

The First National Bank and Trust Company of Newtown Overview

Abbott's FreeStyle Libre 2 iOS App Cleared in U.S., Providing a Seamles's Digital Experience to Simplify Diabetes Management

LibreLinkUp on the App Store

2 Million Patients And Beyond: Abbott's FreeStyle Libre 2 Cleared In The U.S. For Adults And Children With Diabetes

Download the FreeStyle Libre 2 App & LibreLink App

Abbott's FreeStyle Libre 2 app snags FDA clearance to help users manage diabetes

What Is Continuous Glucose Monitoring? (CGM)

Download the FreeStyle Libre 2 App & LibreLink App

Abbott, Sanofi to interconnect their diabetes monitoring, insulin delivery tech